ConductScience.org, home

Paper6940195

Use of anionic liposomes for the reduction of chronic doxorubicin-induced cardiotoxicity.

Forssen EA and 1 other. Proc Natl Acad Sci U S A, 1981. Cited by 162 papers, by iCite.

Cite this record

ConductScience Library. Use of anionic liposomes for the reduction of chronic doxorubicin-induced cardiotoxicity. Papers, record 6940195. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6940195

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Use of anionic liposomes for the reduction of chronic doxorubicin-induced cardiotoxicity.
PubMed
Journal
Proc Natl Acad Sci U S A
PubMed
Year
1981
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
162
iCite
Relative citation ratio, by iCite
5.43
iCite
Revised in PubMed
2019-05-01
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Forssen EAE A
2Tökès ZAZ A

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DoxorubicinMajor topic
HeartMajor topic
LiposomesMajor topic
Animals
Anions
Body Weight
Injections, Intravenous
Leukemia L1210
Leukemia P388
Mice

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
CA-21271NCI NIH HHSUnited StatesR01CA021271PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References21

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14353012A clinicopathologic analysis of adriamycin cardiotoxicity.Cancer1973https://conductscience.org/library/papers/4353012PubMed
27471083Effect of cholesterol content on antitumor activity and toxicity of liposome-encapsulated 1-beta-D-arabinofuranosylcytosine in vivo.Cancer Res1980https://conductscience.org/library/papers/7471083PubMed
31159813Adriamycin-induced cardiac damage in the mouse: a small-animal model of cardiotoxicity.J Natl Cancer Inst1975https://conductscience.org/library/papers/1159813PubMed
41277204Delayed and progressive myocardial lesions after adriamycin administration in the rabbit.Cancer Res1976https://conductscience.org/library/papers/1277204PubMed
59083Affinity of adriamycin to phospholipids. A possible explanation for cardiac mitochondrial lesions.Biochem Biophys Res Commun1976https://conductscience.org/library/papers/9083PubMed
6822941Cardiotoxicity of adriamycin and related anthracyclines.Cancer Treat Rev1976https://conductscience.org/library/papers/822941PubMed
7793635New aspects of liposomes.Biochim Biophys Acta1976https://conductscience.org/library/papers/793635PubMed
8872096Adriamycin-induced cardiotoxicity (cardiomyopathy and congestive heart failure) in rats.Cancer Res1977https://conductscience.org/library/papers/872096PubMed
9909284Subacute cardiotoxicity of adriamycin in the rat: biochemical and ultrastructural investigations.Lab Invest1977https://conductscience.org/library/papers/909284PubMed
10412241Membrane actions of daunorubicin in mammalian erythrocytes.Res Commun Chem Pathol Pharmacol1977https://conductscience.org/library/papers/412241PubMed
11619903Pharmacokinetics of liposome-encapsulated anti-tumor drugs. Studies with vinblastine, actinomycin D, cytosine arabinoside, and daunomycin.Biochem Pharmacol1978https://conductscience.org/library/papers/619903PubMed
12565963Ultrastructural alterations of atrial myocardium induced by adriamycin in chronically treated animals.Tumori1978https://conductscience.org/library/papers/565963PubMed
13279290Liposomes as lysosomotropic carriers.Ann N Y Acad Sci1978https://conductscience.org/library/papers/279290PubMed
14279296Mechanisms of reduction of antitumor drug toxicity by liposome encapsulation.Ann N Y Acad Sci1978https://conductscience.org/library/papers/279296PubMed
15421223Role of liposome type and route of administration in the antitumor activity of liposome-entrapped 1-beta-D-arabinofuranosylcytosine against mouse L1210 leukemia.Cancer Res1979https://conductscience.org/library/papers/421223PubMed
16455325Experimental evaluation of anthracycline analogs.Cancer Treat Rep1979https://conductscience.org/library/papers/455325PubMed
17291473Sudden death during doxorubicin administration.Cancer1979https://conductscience.org/library/papers/291473PubMed
18526304In vitro and in vivo studies with adriamycin liposomes.Biochem Biophys Res Commun1979https://conductscience.org/library/papers/526304PubMed
19526920Quantitative experimental evaluation of adriamycin cardiotoxicity in the mouse.Cancer Treat Rep1979https://conductscience.org/library/papers/526920PubMed
207370991Liposomal protection of adriamycin-induced cardiotoxicity in mice.Cancer Res1980https://conductscience.org/library/papers/7370991PubMed

See all 21 referencesDownload CSV of references

Cited by34

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 162 citations.

PMIDTitleJournalYearIn PapersSource
41252081TLD-1, a Novel Liposomal Doxorubicin, in Patients with Solid Tumors: Comparative Pharmacokinetics and Final Results of a Multicenter Phase 1 Study (SAKK 65/16).Clin Pharmacokinet2026https://conductscience.org/library/papers/41252081PubMed
39885941Thirty years from FDA approval of pegylated liposomal doxorubicin (Doxil/Caelyx): an updated analysis and future perspective.BMJ Oncol2025https://conductscience.org/library/papers/39885941PubMed
39621070The cardio-oncologic burden of breast cancer: molecular mechanisms and importance of preclinical models.Basic Res Cardiol2025https://conductscience.org/library/papers/39621070PubMed
38786467Effects of Anionic Liposome Delivery of All-Trans-Retinoic Acid on Neuroblastoma Cell Differentiation.Biomimetics (Basel)2024https://conductscience.org/library/papers/38786467PubMed
37047585Liposomes in Cancer Therapy: How Did We Start and Where Are We Now.Int J Mol Sci2023https://conductscience.org/library/papers/37047585PubMed
36771161A Review of Different Types of Liposomes and Their Advancements as a Form of Gene Therapy Treatment for Breast Cancer.Molecules2023https://conductscience.org/library/papers/36771161PubMed
34149423Analysis of Models of Doxorubicin-Induced Cardiomyopathy in Rats and Mice. A Modern View From the Perspective of the Pathophysiologist and the Clinician.Front Pharmacol2021https://conductscience.org/library/papers/34149423PubMed
32104444Vesicular nanocarrier based treatment of skin fungal infections: Potential and emerging trends in nanoscale pharmacotherapy.Asian J Pharm Sci2019https://conductscience.org/library/papers/32104444PubMed
30504893Identification of Immune Signatures of Novel Adjuvant Formulations Using Machine Learning.Sci Rep2018https://conductscience.org/library/papers/30504893PubMed
25258527Nanopharmaceuticals (part 1): products on the market.Int J Nanomedicine2014https://conductscience.org/library/papers/25258527PubMed
24277284Stability of liposomes on storage: freeze dried, frozen or as an aqueous dispersion.Pharm Res1984https://conductscience.org/library/papers/24277284PubMed
11718259High concentration of Daunorubicin and Daunorubicinol in human malignant astrocytomas after systemic administration of liposomal Daunorubicin.J Neurooncol2001https://conductscience.org/library/papers/11718259PubMed
10698235Cardiotoxicity of doxorubicin and other anthracycline derivatives.J Nucl Cardiol2000https://conductscience.org/library/papers/10698235PubMed
9063678Diversity of lipid-based polyene formulations and their behavior in biological systems.Eur J Clin Microbiol Infect Dis1997https://conductscience.org/library/papers/9063678PubMed
8855969Immunoliposome-mediated targeting of doxorubicin to human ovarian carcinoma in vitro and in vivo.Br J Cancer1996https://conductscience.org/library/papers/8855969PubMed
8679456An improved method of encapsulation of doxorubicin in liposomes: pharmacological, toxicological and therapeutic evaluation.Br J Cancer1996https://conductscience.org/library/papers/8679456PubMed
8500223Organ distribution and tumor uptake of annamycin, a new anthracycline derivative with high affinity for lipid membranes, entrapped in multilamellar vesicles.Cancer Chemother Pharmacol1993https://conductscience.org/library/papers/8500223PubMed
8269584Identification of vesicle properties that enhance the antitumour activity of liposomal vincristine against murine L1210 leukemia.Cancer Chemother Pharmacol1993https://conductscience.org/library/papers/8269584PubMed
8200855Improvement of therapeutic effect by using Fab' fragment in the treatment of carcinoembryonic antigen-positive human solid tumors with adriamycin-entrapped immunoliposomes.Jpn J Cancer Res1994https://conductscience.org/library/papers/8200855PubMed
7950152Liposomal doxorubicin in AIDS-related Kaposi's sarcoma: long-term experiences.Clin Investig1994https://conductscience.org/library/papers/7950152PubMed

See all 34 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6940195

GET https://conductscience.org/api/papers/v1/6940195/references?page=2